Figure 1.
Drug loading and characterization of the particles. (A) The schematic structure of PEG-PCL-DAC-BTZ prepared in this study; (B) the morphology of PEG-PCL-DAC-BTZ by transmission electron microscopy (TEM); (C and D) dynamic light scattering characterization of unloaded particles, PEG-PCL, and drug-loaded particles, PEG-PCL-DAC-BTZ; and (E) stability characterization using dynamic light scattering. Particles were placed in dialysis bags against PBS for 1, 15, and 30 days. (F) DAC release profile of the PEG-PCL-DAC-BTZ nanoparticle system.